STAT Plus: Pharmalittle: White House signs deal for U.S.-made generics to fight Covid-19; Gilead expands remdesivir donations
The Trump administration signed a contract with Phlow, a new company in Richmond, Va., to make generic drugs and pharmaceutical ingredients needed to treat Covid-19.
by Ed Silverman
May 19, 2020
1 minute
Rise and shine, another brand new day is here. Thanks to a sunny sky and some cool breezes, we are finding it easy enough to deflect the chaos and concern permeating the world around us. A few
You’re reading a preview, subscribe to read more.
Start your free 30 days